Worth Seeing!
Best Stocks from Nifty 500 View list Now View list Now
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 73878.15
732.96 (-0.98%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
31
Indoco Remedies Ltd.
3,110
(Small Cap)
337.50
(1.69%)
29.77
2.86
9.93
28.74
Q V PT
32
Gufic Biosciences Ltd.
3,224
(Small Cap)
323.30
(-1.81%)
38.29
6.29
17.71
34.15
Q V PT
33
Supriya Lifescience Ltd.
3,301
(Small Cap)
412.25
(-1.55%)
27.41
4.22
16.71
67.00
Q V+ PT
34
Thyrocare Technologies Ltd.
3,346
(Small Cap)
632
(-1.48%)
51.01
6.68
8.13
-7.14
Q V PT
35
Dishman Carbogen Amcis Ltd.
3,584
(Small Cap)
227.80
(-1.02%)
N/A
0.63
7.32
-23.69
Q V PT
36
Hikal Ltd.
3,668
(Small Cap)
297.10
(-1.83%)
51.2
3.16
9.31
-0.88
Q V PT
37
Yatharth Hospital & Trauma Care Services Ltd.
3,886
(Small Cap)
452.65
(1.73%)
60.55
4.79
0.00
0.00
Q V PT
38
Unichem Laboratories Ltd.
4,231
(Small Cap)
598.50
(2.31%)
N/A
1.76
9.99
0.00
Q V PT
39
Kovai Medical Center & Hospital Ltd.
4,352
(Small Cap)
3,977.40
(-2.05%)
27.53
5.22
11.48
15.15
Q V+ PT
40
AMI Organics Ltd.
4,393
(Small Cap)
1,191.25
(-1.93%)
113.34
6.85
26.79
33.72
Q V PT
41
Advanced Enzyme Technologies Ltd.
4,408
(Small Cap)
393.35
(-0.54%)
35.99
7.66
8.00
9.23
Q V PT
42
Aarti Drugs Ltd.
4,609
(Small Cap)
498.60
(-0.29%)
26.89
3.6
16.91
15.52
Q V PT
43
Aarti Pharmalabs Ltd.
4,634
(Small Cap)
518
(1.27%)
26.09
2.94
0.00
0.00
Q V+ PT
44
Healthcare Global Enterprises Ltd.
5,147
(Small Cap)
369.25
(4.19%)
128.99
4.34
11.39
7.94
Q V PT
45
Shilpa Medicare Ltd.
5,236
(Small Cap)
540.85
(-2.36%)
N/A
2.29
5.89
-183.46
Q V PT
46
Blue Jet Healthcare Ltd.
6,423
(Small Cap)
370
(-2.81%)
40.14
3.91
0.00
0.00
Q V PT
47
Vijaya Diagnostic Centre Ltd.
6,996
(Small Cap)
680
(0.67%)
61.99
11.22
0.00
0.00
Q V PT
48
FDC Ltd.
7,309
(Small Cap)
451.80
(1.16%)
24.67
3.57
10.84
3.42
Q V+ PT
49
Sun Pharma Advanced Research Company Ltd.
7,321
(Small Cap)
225.60
(-4.99%)
N/A
31.55
24.99
0.00
Q V+ PT
50
Marksans Pharma Ltd.
7,532
(Small Cap)
165.80
(-1.04%)
63.52
6.33
17.33
59.01
Q V PT
51
Procter & Gamble Health Ltd.
7,883
(Small Cap)
4,755.20
(-1.14%)
36.83
9.25
11.99
36.80
Q V PT
52
Jupiter Life Line Hospitals Ltd.
8,020
(Small Cap)
1,231.50
(2.10%)
74.8
6.67
19.71
26.72
Q V PT
53
Strides Pharma Science Ltd.
8,120
(Small Cap)
896.80
(-0.13%)
109.4
2.3
4.76
-151.49
Q V PT
54
Wockhardt Ltd.
8,455
(Small Cap)
551.15
(-3.23%)
N/A
2.4
-7.60
0.00
Q V PT
55
Metropolis Healthcare Ltd.
9,174
(Small Cap)
1,798.85
(-0.53%)
73.53
8.54
12.15
6.00
Q V PT
56
Neuland Laboratories Ltd.
9,675
(Small Cap)
7,604.95
(-0.74%)
30.57
8.02
17.70
56.85
Q V+ PT
57
Caplin Point Laboratories Ltd.
9,863
(Small Cap)
1,303.05
(-2.11%)
22.54
4.5
22.13
21.09
Q V PT
58
Granules India Ltd.
10,261
(Small Cap)
422
(-0.69%)
22.11
3.41
19.01
31.51
Q V PT
59
Jubilant Pharmova Ltd.
10,932
(Small Cap)
688.50
(1.84%)
N/A
4.68
-24.52
-28.13
Q V+ PT
60
Eris Lifesciences Ltd.
11,796
(Small Cap)
867.05
(-2.68%)
30.52
4.69
14.52
6.67
Q V PT
2

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Ajanta Pharma
2,3776.44%
Piramal Pharma
151.105.59%
RainbowChildrenS Med
1,449.404.56%
HealthcareGlobal
369.254.19%
Solara Active Pharma
552.653.71%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Bliss GVS Pharma
119.10-7.82%
Sun Pharma Adv. Res
225.60-4.99%
NGL Fine-Chem
2,519.25-4.38%
Medicamen Biotech
539.10-3.56%
Wockhardt
551.15-3.23%
View More

News about Top Pharma Companies in India

Aarti Pharmalabs submits board meeting intimation

Aarti Pharmalabs has informed that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024, to consider and approve Audited Financial Results for the quarter ended March 31, 2024; Audited Financial Statements for the year ended March 31, 2024; Recommend Final Dividend, if any, for the year ended March 31, 2024; Approve any other business matter, if required, with the permission of Chair. 

The above information is a part of company’s filings submitted to BSE.
04 May, 2024

Aarti Drugs - Quaterly Results

Net sales declined -19.66%  to  Rs. 5595.30 million from Rs. 6964.10 millions.The Net Profit of the company slipped to Rs. 361.40 millions from Rs. 531.70 millions, a decline of -32.03% on QoQ basis.Operating profit for the quarter ended March 2024 decreased to 701.70 millions as compared to 894.50 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5595.30 6964.10 -19.66 22669.10 24979.70 -9.25 22669.10 24979.70 -9.25
Other Income 11.10 9.30 19.35 41.80 22.30 87.44 41.80 22.30 87.44
PBIDT 701.70 894.50 -21.55 2703.10 2846.30 -5.03 2703.10 2846.30 -5.03
Interest 80.90 83.50 -3.11 301.60 325.30 -7.29 301.60 325.30 -7.29
PBDT 620.80 811.00 -23.45 2401.50 2521.00 -4.74 2401.50 2521.00 -4.74
Depreciation 123.40 116.80 5.65 476.70 472.90 0.80 476.70 472.90 0.80
PBT 497.40 694.20 -28.35 1924.80 2048.10 -6.02 1924.80 2048.10 -6.02
TAX 136.00 162.50 -16.31 506.00 520.00 -2.69 506.00 520.00 -2.69
Deferred Tax -15.00 -15.00 0.00 10.00 -12.50 -180.00 10.00 -12.50 -180.00
PAT 361.40 531.70 -32.03 1418.80 1528.10 -7.15 1418.80 1528.10 -7.15
Equity 919.40 926.00 -0.71 919.40 926.00 -0.71 919.40 926.00 -0.71
PBIDTM(%) 12.54 12.84 -2.36 11.92 11.39 4.65 11.92 11.39 4.65
03 May, 2024

Aarti Drugs - Quaterly Results

A decrease in the sales to Rs. 5595.30 millions was observed for the quarter ended March 2024. The sales stood at Rs. 6964.10 millions during the similar quarter previous year.The Company to register a -32.03%  fall in the net profit for the quarter ended March 2024.The company reported a degrowth in operating Profit to 701.70 millions from 894.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5595.30 6964.10 -19.66 22669.10 24979.70 -9.25 22669.10 24979.70 -9.25
Other Income 11.10 9.30 19.35 41.80 22.30 87.44 41.80 22.30 87.44
PBIDT 701.70 894.50 -21.55 2703.10 2846.30 -5.03 2703.10 2846.30 -5.03
Interest 80.90 83.50 -3.11 301.60 325.30 -7.29 301.60 325.30 -7.29
PBDT 620.80 811.00 -23.45 2401.50 2521.00 -4.74 2401.50 2521.00 -4.74
Depreciation 123.40 116.80 5.65 476.70 472.90 0.80 476.70 472.90 0.80
PBT 497.40 694.20 -28.35 1924.80 2048.10 -6.02 1924.80 2048.10 -6.02
TAX 136.00 162.50 -16.31 506.00 520.00 -2.69 506.00 520.00 -2.69
Deferred Tax -15.00 -15.00 0.00 10.00 -12.50 -180.00 10.00 -12.50 -180.00
PAT 361.40 531.70 -32.03 1418.80 1528.10 -7.15 1418.80 1528.10 -7.15
Equity 919.40 926.00 -0.71 919.40 926.00 -0.71 919.40 926.00 -0.71
PBIDTM(%) 12.54 12.84 -2.36 11.92 11.39 4.65 11.92 11.39 4.65
03 May, 2024

Procter&Gamble Healt - Quaterly Results

The sales is pegged at Rs. 2524.80 millions for the March 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 3209.20 millions during the year-ago period.The Company's Net profit for the March 2024 quarter have declined marginally to Rs. 465.60  millions as against Rs. 591.90 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 697.10 millions from 846.30 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202306 202206 % Var
Sales 2524.80 3209.20 -21.33 8673.80 9284.40 -6.58 12296.20 11144.10 10.34
Other Income 22.70 49.70 -54.33 135.00 129.30 4.41 183.90 131.90 39.42
PBIDT 697.10 846.30 -17.63 2712.50 2922.70 -7.19 3430.70 2808.70 22.15
Interest 1.50 2.10 -28.57 5.20 6.00 -13.33 7.70 4.20 83.33
PBDT 695.60 844.20 -17.60 2707.30 2916.70 -7.18 3423.00 2804.50 22.05
Depreciation 68.40 58.90 16.13 202.40 216.00 -6.30 281.00 270.80 3.77
PBT 627.20 785.30 -20.13 2504.90 2700.70 -7.25 3142.00 2533.70 24.01
TAX 161.60 193.40 -16.44 662.90 704.20 -5.86 847.30 608.50 39.24
Deferred Tax -1.40 -33.70 -95.85 -18.60 -42.60 -56.34 -50.60 0.40 -12750.00
PAT 465.60 591.90 -21.34 1842.00 1996.50 -7.74 2294.70 1925.20 19.19
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 27.61 26.37 4.70 31.27 31.48 -0.66 27.90 25.20 10.70
02 May, 2024

Procter&Gamble Healt - Quaterly Results

The sales declined to Rs. 2524.80 millions for the March 2024 quarter as compared to Rs. 3209.20 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -21.34% to Rs. 465.60  millions from Rs. 591.90 millions.A decline of 697.10 millions was observed in the OP in the quarter ended March 2024 from 846.30 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202306 202206 % Var
Sales 2524.80 3209.20 -21.33 8673.80 9284.40 -6.58 12296.20 11144.10 10.34
Other Income 22.70 49.70 -54.33 135.00 129.30 4.41 183.90 131.90 39.42
PBIDT 697.10 846.30 -17.63 2712.50 2922.70 -7.19 3430.70 2808.70 22.15
Interest 1.50 2.10 -28.57 5.20 6.00 -13.33 7.70 4.20 83.33
PBDT 695.60 844.20 -17.60 2707.30 2916.70 -7.18 3423.00 2804.50 22.05
Depreciation 68.40 58.90 16.13 202.40 216.00 -6.30 281.00 270.80 3.77
PBT 627.20 785.30 -20.13 2504.90 2700.70 -7.25 3142.00 2533.70 24.01
TAX 161.60 193.40 -16.44 662.90 704.20 -5.86 847.30 608.50 39.24
Deferred Tax -1.40 -33.70 -95.85 -18.60 -42.60 -56.34 -50.60 0.40 -12750.00
PAT 465.60 591.90 -21.34 1842.00 1996.50 -7.74 2294.70 1925.20 19.19
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 27.61 26.37 4.70 31.27 31.48 -0.66 27.90 25.20 10.70
02 May, 2024

Ami Organics informs about board meeting

Ami Organics has informed that meeting of the Board of Directors of the Company is scheduled to be held on May 10, 2024, to consider the recommendation of final dividend for the FY 2023-24 as per the details attached.

The above information is a part of company’s filings submitted to BSE.

02 May, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Medicamen Biotech Ltd. 685 Crore
2 Panacea Biotec Ltd. 856 Crore
3 Bajaj Healthcare Ltd. 889 Crore
4 Jagsonpal Pharmaceuticals Ltd. 946 Crore
5 Sastasundar Ventures Ltd. 974 Crore
6 Vimta Labs Ltd. 1,161 Crore
7 Lincoln Pharmaceuticals Ltd. 1,196 Crore
8 Kopran Ltd. 1,205 Crore
9 Bliss GVS Pharma Ltd. 1,247 Crore
10 Syncom Formulations (India) Ltd. 1,311 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,628 19,845 32.90 20.95 22.36 51.69
Abbott India Ltd. (M) Very Good 26,171 55,555 48.50 16.24 33.08 31.69
Laurus Labs Ltd. (S) Very Good 447.3 24,108 150.2 5.86 32.93 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 6,333 1,05,929 20.26 3.94 12.27 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,733 92,484 61.90 12.93 29.66 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Lupin Ltd. (M) Somewhat Good 1,663 75,438 133.8
Glenmark Pharmaceuticals Ltd. (S) Somewhat Good 1,053 29,743 94.86
Zydus Lifesciences Ltd. (L) Very Good 992.0 1,00,322 91.56
Ipca Laboratories Ltd. (M) Very Good 1,333 33,897 88.78
Aurobindo Pharma Ltd. (M) Very Good 1,153 67,541 87.07
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 447.3 24,108 150.2 5.86 32.93 24.05
Granules India Ltd. (S) Somewhat Good 422.0 10,261 22.11 3.41 13.38 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,872 29,312 57.91 10.43 34.20 18.11
Gland Pharma Ltd. (M) Very Good 1,689 27,734 34.62 3.20 19.64 17.42
Mankind Pharma Ltd. (L) Very Good 2,305 92,708 56.18 10.12 38.80 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 447.3 24,108 150.2 5.86 32.93 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 6,333 1,05,929 20.26 3.94 12.27 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,872 29,312 57.91 10.43 34.20 31.92
Biocon Ltd. (M) Somewhat Good 305.2 36,642 19.12 3.37 98.65 31.80
Granules India Ltd. (S) Somewhat Good 422.0 10,261 22.11 3.41 13.38 31.51
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
SEBI Registered: Investment Adviser - INA000013323
Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.